Although a definite role for Cav-1 in diabetes has not been fully elucidated, it is apparent that modulating eNOS function by Cav-1 could be beneficial in ameliorating diabetes mediated endothelial dysfunction. Here, NOS3 is linked to endothelial dysfunction.